Figure 6.
Immunohistochemistry. (A) Most cases of α-fetoprotein-producing endometrial carcinoma were p53-aberrant on immunohistochemistry (case 5 shown). (B) Only one case in our series was p53-wildtype (case 4). (C) Some overexpressed HER2 (case 5). (D) One case (case 2) in our series showed subclonal loss of expression of MLH1 and PMS2 (not shown). Original magnification× 100 (A–C) and ×40 (D), scale bars = 200 μm (A–C) and 500 μm (D).